This was reinforced in this work through the pharmacological reestablishment of 5mC and 5hmC levels, using a DNMTs inhibitor and a TETs cofactor, which successfully rescued KMT5B expression in our human GBM cell line LN-229. This evidence concerns the gene KMT5B and glioblastoma.